The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Mylan

Trends Update — Shifting IP Constituencies: Perkin Elmer and Mylan in India, Branded Generics Everywhere and China’s R&D Budget all Point to Change

world_map_2002In our continuing Trends in 2009 series on shifting IP constituencies, we’ve been following increasing innovative activity in the developing world, and innovator pharma’s increasing moves towards generics and biosimilars.  This week saw updates on both fronts:

Bookmark and Share

Follow

Get every new post delivered to your Inbox.

Join 130 other followers